Split aptamer regulated CRISPR/Cas12a biosensor for 17β-estradiol through a gap-enhanced Raman tags based lateral flow strategy

Biosens Bioelectron. 2022 Nov 1:215:114548. doi: 10.1016/j.bios.2022.114548. Epub 2022 Jul 12.

Abstract

It is significant to exploit the full potential of CRISPR/Cas based biosensor for non-nucleic-acid targets. Here, we developed a split aptamer regulated CRISPR/Cas12a and gap-enhanced Raman tags based lateral flow biosensor for small-molecule target, 17β-estradiol. In this assay, one split aptamer of 17β-estradiol was designed to complement with crRNA of Cas12a so that the trans-cleavage ability of CRISPR/Cas12a can be regulated by the competitive binding of 17β-estradiol and split aptamers. Through integration of the signal amplification ability of CRISPR/Cas12a and the ultra-sensitive gap-enhanced Raman tags based lateral flow assay, a visible-SERS dual mode determination of 17β-estradiol can be established. 17β-estradiol can be visibly recognized as low as 10 pM and accurately quantified with a detection limit of 180 fM by SERS signals, which is at least 103-fold lower than that of the previous immunoassay lateral flow strategies. Our assay provides a novel perspective to develop split aptamer regulated CRISPR/Cas12a coupling with SERS lateral flow strips for ultrasensitive and easy-to-use non-nucleic-acid targets detection.

Keywords: 17β-estradiol; CRISPR/Cas12a; Gap-enhanced Raman tags; Lateral flow assay; Split aptamers.

MeSH terms

  • Aptamers, Nucleotide* / chemistry
  • Biosensing Techniques*
  • CRISPR-Cas Systems / genetics
  • Estradiol / chemistry

Substances

  • Aptamers, Nucleotide
  • Estradiol